» Articles » PMID: 38554046

Analysis of Sex Hormones, Insulin Dosage, and Risk Factors Associated With Male Diabetic Patients

Overview
Date 2024 Mar 30
PMID 38554046
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study is to assess the influence of sex hormones and other indicators on risk factors for hypercoagulable states in male patients with type 2 diabetes mellitus. Ninety-two diabetic patients were divided into two groups based on testosterone levels: T1 group (testosterone <12 mmol/L) and T2 group (testosterone >12 mmol/L). Fifty-four non-diabetic patients were used as the control group. Sex hormone index, glucose, insulin, C-peptide, 24-h urinary free cortisol, thromboelastography, and insulin resistance index were measured by radioimmunoassay. Testosterone was lower in the diabetic men than in the control group (12.02 vs 14.77, < .05), and was inversely related to blood coagulation status, blood glucose level, and cortisol level. Body mass index was positively correlated with estradiol and insulin resistance index. Testosterone was independently associated with the clotting process after controlling for age. Low testosterone is a risk factor for hypercoagulable state in diabetic men. Elevated estradiol and insulin resistance are influential factors for increased body mass index.

Citing Articles

Association between endogenous estradiol, testosterone, and long-term mortality in adults with prediabetes and diabetes: Evidence from NHANES database.

Feng Y, Jin X, Zhu J, Yuan M, Zhu L, Ye D J Diabetes Investig. 2024; 16(3):481-491.

PMID: 39705158 PMC: 11871383. DOI: 10.1111/jdi.14367.

References
1.
Cheung K, Luk A, So W, Ma R, Kong A, Chow F . Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence. J Diabetes Investig. 2015; 6(2):112-23. PMC: 4364844. DOI: 10.1111/jdi.12288. View

2.
Herring M, Oskui P, Hale S, Kloner R . Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2013; 2(4):e000271. PMC: 3828782. DOI: 10.1161/JAHA.113.000271. View

3.
Kelly D, Jones T . Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013; 217(3):R25-45. DOI: 10.1530/JOE-12-0455. View

4.
Sattar N, Boyle J, Al-Ozairi E . Testosterone replacement to prevent type 2 diabetes? Not just yet. Lancet Diabetes Endocrinol. 2020; 9(1):5-6. DOI: 10.1016/S2213-8587(20)30373-9. View

5.
Hobaus C, Herz C, Wrba T, Koppensteiner R, Schernthaner G . Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control. Diab Vasc Dis Res. 2020; 17(2):1479164120914845. PMC: 7510380. DOI: 10.1177/1479164120914845. View